Recent Updates
Recently added Catalysts
ARAY Positive Sentiment Score: 75/100

Accuray to Participate in the B. Riley Securities

Tuesday, January 10, 2023 2 min read
Key Takeaway: Accuray Incorporated (NASDAQ: ARAY) has announced its participation in the B. Riley Securities' 3rd Annual Oncology Conference, scheduled for January 18-19, 2023. The company's management team will engage in a virtual Fireside Chat on January 18 at 7:00am PST/10:00am EST. The conference will feature over 30 small and mid-cap healthcare companies and discuss advancements in various oncological therapies, including immunotherapy and radiation oncology. Accuray aims to expand its innovative radiation therapy solutions to enhance patient care.

Market Sentiment Analysis

POSITIVE FACTORS

  • Accuray is participating in a prominent oncology conference.
  • The conference showcases advancements in cancer treatment technologies.
  • Accuray's commitment to innovation in radiation therapy is highlighted.

Full Press Release Details

Company to Take Part in Fireside Chat Wednesday, January 18, 2023 at 7:00am PST/10:00am EST
SUNNYVALE, Calif., Jan. 10, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the B. Riley Securities' 3rd Annual Oncology Conference taking place January 18-19, 2023. The management team is scheduled to participate in a virtual Fireside Chat on Wednesday, January 18, 2023 at 7:00am PST/10:00am EST.
A live webcast of the Fireside Chat can be accessed on the Accuray website at investors.accuray.com. A replay will be available on the Company's website following the event.
B. Riley Securities 3rd Annual Oncology Conference, January 18-19, will feature over 30 SMiD cap healthcare companies focused on the development and commercialization of new medicines and key enabling technologies, cutting across multiple next-generation therapeutic modalities. The conference will feature KOL panel discussions with academic and industry leaders at the forefront of translational and clinical research underway with novel immunotherapy, cell therapy, and targeted oncology approaches, as well as imaging and radiation oncology initiatives, aimed at driving meaningful improvements to current standard of care for cancer patients.
Accuray Incorporated is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions that are designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Sunnyvale, California, with facilities worldwide.
Investor Relations, ICR-Westwicke
Public Relations Director, Accuray
SOURCE Accuray Incorporated

21 %

more press release views with

Frequently Asked Questions

When is Accuray's Fireside Chat scheduled?

The Fireside Chat is on January 18, 2023, at 7:00am PST/10:00am EST.

Where can I watch the Fireside Chat live?

The live webcast is available on the Accuray website at investors.accuray.com.

What is the focus of the B. Riley Securities Conference?

The conference focuses on new medicines and technologies in oncology.

What is Accuray's mission in radiation therapy?

Accuray aims to enhance radiation therapy to improve patient lives effectively.

Where is Accuray Incorporated headquartered?

Accuray is headquartered in Sunnyvale, California.

Tags: ARAY Viatris Investor Conferences Healthcare Accuray radiation therapy oncology conference B. Riley Securities cancer treatment
Last updated: Jan 10, 2023